Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Urogen Pharma Ltd URGN

Healthcare Biotechnology
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel... see more

Recent & Breaking News (NDAQ:URGN)

UroGen Pharma’s Chairman, Arie Belldegrun, MD, FACS to Receive EY 2018 Master Entrepreneur Award

GlobeNewswire June 13, 2018

UroGen Pharma Announces Stephen Mullennix as Interim Chief Financial Officer and Jason Patel as Vice President of Finance

GlobeNewswire June 5, 2018

UroGen Pharma to Present at the Jefferies 2018 Global Healthcare Conference

GlobeNewswire May 29, 2018

UroGen Pharma Reports First Quarter 2018 Financial Results and Recent Corporate Developments

GlobeNewswire May 15, 2018

UroGen Pharma to Report First Quarter 2018 Financial Results on Tuesday, May 15, 2018

GlobeNewswire May 8, 2018

UroGen Pharma Announces Presentation of Results from Interim Analysis of Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)

GlobeNewswire April 3, 2018

Research Report Identifies Prothena, UROGEN PHARMA, Mizuho Financial Group, 1-800 FLOWERS.COM, Willis Towers Watson Public, and First Connecticut with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

GlobeNewswire March 15, 2018

UroGen Reports Fourth Quarter and Full Year 2017 Financial Results

GlobeNewswire March 15, 2018

UroGen Pharma to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 15, 2018

GlobeNewswire March 8, 2018

UroGen to Present at March 2018 Investor Conferences

GlobeNewswire March 7, 2018

7 Stocks Moving In Thursday's After-Hours Session

Benzinga.com  January 25, 2018

UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters' Option

GlobeNewswire January 23, 2018

UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares

GlobeNewswire January 18, 2018

UroGen Pharma Announces Proposed Public Offering of Ordinary Shares

GlobeNewswire January 16, 2018

UroGen Pharma Appoints Former Kite Pharma Executive Christine Cassiano as Corporate Affairs Officer

GlobeNewswire January 8, 2018

UroGen Pharma to Present at the 36th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 2, 2018

UroGen Pharma Expands Clinical Development Leadership Team

GlobeNewswire December 12, 2017

UroGen Pharma Announces Oral Presentation at Society of Urologic Oncology (SUO) Annual Meeting

GlobeNewswire November 27, 2017

UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments

GlobeNewswire November 14, 2017

UroGen Pharma to Present at the Jefferies 2017 London Healthcare Conference

GlobeNewswire November 9, 2017